학술논문

Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA
Document Type
Article
Source
In: Clinical Lymphoma, Myeloma and Leukemia. (Clinical Lymphoma, Myeloma and Leukemia, August 2022, 22(8):e804-e814)
Subject
Language
English
ISSN
21522669
21522650